302 related articles for article (PubMed ID: 19462465)
1. Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling.
Blake PW; Toro JR
Hum Mutat; 2009 Jul; 30(7):1025-36. PubMed ID: 19462465
[TBL] [Abstract][Full Text] [Related]
2. Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens.
Grossmann P; Vanecek T; Steiner P; Kacerovska D; Spagnolo DV; Cribier B; Rose C; Vazmitel M; Carlson JA; Emberger M; Martinek P; Pearce RL; Pearn J; Michal M; Kazakov DV
Am J Dermatopathol; 2013 Feb; 35(1):34-44. PubMed ID: 23249834
[TBL] [Abstract][Full Text] [Related]
3. CYLD mutations in familial skin appendage tumours.
Saggar S; Chernoff KA; Lodha S; Horev L; Kohl S; Honjo RS; Brandt HR; Hartmann K; Celebi JT
J Med Genet; 2008 May; 45(5):298-302. PubMed ID: 18234730
[TBL] [Abstract][Full Text] [Related]
4. Large germline deletions of the CYLD gene in patients with Brooke-Spiegler syndrome and multiple familial trichoepithelioma.
Vanecek T; Halbhuber Z; Kacerovska D; Martinek P; Sedivcova M; Carr RA; Slouka D; Michal M; Kazakov DV
Am J Dermatopathol; 2014 Nov; 36(11):868-74. PubMed ID: 25347032
[TBL] [Abstract][Full Text] [Related]
5. Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes.
Ponti G; Nasti S; Losi L; Pastorino L; Pollio A; Benassi L; Giudice S; Bertazzoni G; Veratti E; Azzoni P; Bianchi Scarrà G; Seidenari S
J Cutan Pathol; 2012 Mar; 39(3):366-71. PubMed ID: 22077640
[TBL] [Abstract][Full Text] [Related]
6. A case of Brooke-Spiegler syndrome with a novel mutation in the CYLD gene in a patient with aggressive non-Hodgkin's lymphoma.
Hunstig F; Schulz S; Nieten I; Froster U; Boltze C; Schliemann S; Hochhaus A; La Rosée P
J Cancer Res Clin Oncol; 2016 Apr; 142(4):845-8. PubMed ID: 26660106
[TBL] [Abstract][Full Text] [Related]
7. Phenotype-genotype correlations for clinical variants caused by CYLD mutations.
Nagy N; Farkas K; Kemény L; Széll M
Eur J Med Genet; 2015 May; 58(5):271-8. PubMed ID: 25782638
[TBL] [Abstract][Full Text] [Related]
8. Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity.
Almeida S; Maillard C; Itin P; Hohl D; Huber M
J Invest Dermatol; 2008 Mar; 128(3):587-93. PubMed ID: 17851586
[TBL] [Abstract][Full Text] [Related]
9. Phenotype variability in tumor disorders of the skin appendages associated with mutations in the CYLD gene.
Parren LJMT; Giehl K; van Geel M; Frank J
Arch Dermatol Res; 2018 Sep; 310(7):599-606. PubMed ID: 29974194
[TBL] [Abstract][Full Text] [Related]
10. CYLD GeneticTesting for Brooke-Spiegler Syndrome, Familial Cylindromatosis and Multiple Familial Trichoepitheliomas.
Dubois A; Wilson V; Bourn D; Rajan N
PLoS Curr; 2015 Feb; 7():. PubMed ID: 25737804
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation.
Bowen S; Gill M; Lee DA; Fisher G; Geronemus RG; Vazquez ME; Celebi JT
J Invest Dermatol; 2005 May; 124(5):919-20. PubMed ID: 15854031
[TBL] [Abstract][Full Text] [Related]
12. Multiple (familial) trichoepitheliomas: a clinicopathological and molecular biological study, including CYLD and PTCH gene analysis, of a series of 16 patients.
Kazakov DV; Vanecek T; Zelger B; Carlson JA; Spagnolo DV; Schaller J; Nemcova J; Kacerovska D; Vazmitel M; Sangüeza M; Emberger M; Belousova I; Fernandez-Figueras MT; Kempf W; Meyer DR; Rütten A; Baltaci M; Michal M
Am J Dermatopathol; 2011 May; 33(3):251-65. PubMed ID: 21389835
[TBL] [Abstract][Full Text] [Related]
13. A novel missense mutation in CYLD in a family with Brooke-Spiegler syndrome.
Hu G; Onder M; Gill M; Aksakal B; Oztas M; Gürer MA; Celebi JT
J Invest Dermatol; 2003 Oct; 121(4):732-4. PubMed ID: 14632188
[TBL] [Abstract][Full Text] [Related]
14. [Brooke-Spiegler syndrome: an heterogeneous entity].
Mataix J; Bañuls J; Botella R; Laredo C; Lucas A
Actas Dermosifiliogr; 2006 Dec; 97(10):669-72. PubMed ID: 17173833
[TBL] [Abstract][Full Text] [Related]
15. A novel missense mutation of the CYLD gene identified in a Hungarian family with Brooke-Spiegler syndrome.
Nagy N; Farkas K; Kinyo A; Nemeth IB; Kis E; Varga J; Bata-Csorgo Z; Kemeny L; Szell M
Exp Dermatol; 2012 Dec; 21(12):967-9. PubMed ID: 23171463
[TBL] [Abstract][Full Text] [Related]
16. Heterozygous Cylindromatosis Gene Mutation c.1628_1629delCT in a Family with Brook-Spiegler Syndrome.
Aguilera CA; De la Varga Martínez R; García LO; Jiménez-Gallo D; Planelles CA; Barrios ML
Indian J Dermatol; 2016; 61(5):580. PubMed ID: 27688459
[TBL] [Abstract][Full Text] [Related]
17. Clinical, genetic and experimental studies of the Brooke-Spiegler (CYLD) skin tumor syndrome.
Andersson MK; Kölby L; Nilsson JA; Stenman G
J Plast Surg Hand Surg; 2019 Apr; 53(2):71-75. PubMed ID: 30676842
[TBL] [Abstract][Full Text] [Related]
18. A novel CYLD germline mutation in Brooke-Spiegler syndrome.
Guardoli D; Argenziano G; Ponti G; Nasti S; Zalaudek I; Moscarella E; Lallas A; Piana S; Specchio F; Martinuzzi C; Raucci M; Pellacani G; Longo C
J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):457-62. PubMed ID: 25131725
[TBL] [Abstract][Full Text] [Related]
19. A novel large deletion of the CYLD gene causes CYLD cutaneous syndrome in a Chinese family.
Zhu R; Xu J; Shen J; Li W; Tan F; Li C; Wei Z; Liu Y; Bai Y
Mol Genet Genomic Med; 2020 Oct; 8(10):e1441. PubMed ID: 32783365
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
